| Study title |
Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN) |
| Disease or condition |
Primary biliary cholangitis |
| Study type |
Interventional (Clinical Trial) |
| Intervention/treatment |
Linerixibat |
| Phase |
3 |
| Study site |
Duke University |
| Study location |
Durham |
| Principal investigator name and email |
Andrew Muir, MD andrew.muir@duke.edu |
| Study coordinator name and email |
Adele Gaskin, adele.gaskin@duke.edu |
| Phone contact |
919-684-0742 |
| Clinicaltrials.gov link |
https://clinicaltrials.gov/ct2/show/record/NCT04950127 |
